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Background: Birth defects (BD) constitute an important public health issue as they are the main cause of infant death.
Their prevalence in Europe for 2008–2012 was 25.6 per 1000 newborns. To date, there are no population-based studies
for the Russian Federation. The aim of the present study is to estimate the prevalence of BD, its forms, and changes
over time in the Russian Arctic city of Monchegorsk (Murmansk County) for the period 1973–2011.
Methods: The Murmansk County Birth Register and the Kola Birth Register were the primary sources of information,
covering 30448 pregnancy outcomes in Monchegorsk (Murmansk County, Russia) during the study period.
Results: The total perinatal prevalence of BD was 36.1/1000 live births (LB) and stillborn (SB) (95% CI = 34.0-38.2). After
exclusions of minor malformations according to the European Surveillance of Congenital Anomalies guidelines, it
decreased to 26.5/1000 LB plus SB (95% CI = 24.6-28.3). The perinatal prevalence of BD that are obligatory to report in
Russia was 7.3/1000 LB plus SB (95% CI = 6.4-8.3). There was a significant positive time-trend in total perinatal prevalence
of birth defects across the study period (p < 0.001 for trend). Prevalence of all BD increased from 23.5/1000 to 46.3/1000
(LB plus SB), while that excluding minor defects rose from 17.7/1000 to 35.7/1000 (LB plus SB). The most prevalent
group of defects was malformations of the musculoskeletal system, which represented 35.4% of all BD. The most
prominent increase was observed for the urinary system, rising from 0.2/1000 to 19.1/1000 (LB plus SB).
Conclusions: The observed perinatal prevalence of BD in Monchegorsk increased two-fold during the 38-year
study period. Further investigations to identify the underlying bases for the observed progressive growth in BD
are recommended.
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Birth defects (BD) are recognized by the World Health
Organization (WHO) as structural or functional anomalies
that are present from birth. They represent the main causes
of infant deaths and morbidity in developed countries. The
prevalence of BD in Europe is reported as 25.6/1000
newborns [live births (LB) plus stillborn (SB)] for the
period 2008–2012 (European Surveillance of Congenital
Anomalies, EUROCAT, data [1]). About 20% of deaths
under one year of age are due to congenital anomalies [2].
Birth defects are a wide group of ontogenetic disorders
which can be caused by single gene defects, chromosomal* Correspondence: vpo000@post.uit.no
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unless otherwise stated.disorders, multifactorial inheritance factors, occupational/
environmental teratogens, micronutrient deficiencies,
among other risks [3].
It has been reported that 42% of perinatal deaths are
directly or indirectly connected with BD in the Russian
Federation (RF) [4]. However, the estimates of BD preva-
lence in the RF cannot be considered comparable with
those derived from European and world-based registers
because of differences in surveillance protocols (e.g., the
limited number of BD forms requiring mandatory regis-
tration in Russia) [5]. There is only one register in the
Moscow Oblast, which joined the International Clear-
inghouse for Birth Defects Surveillance and Research
(ICBDSR) as a member in 2001 [6]. This organization
collects data for about 40 of the most severe anomalies
and, based on this, the prevalence of BD in the Moscowl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and 6.1/1000 (LB plus SB) in 2009 [6,7].
For the period March 1973 through 2002, Vaktskjold
et al. reported a high prevalence (13.3/1000 of newborns)
of musculoskeletal malformations in Monchegorsk [8], but
not of genital defects (4.4/1000 newborns) [9]. Further-
more, for 1995–2004 Petrova and Vaktskjold found a
higher incidence of neural tube defects (2.1/1000 newborns
and abortions) in Arkhangelsk, Russia than in Norway
[10]; by contrast, the incidences of anterior abdominal wall
defects were the same (0.5/1000 newborns and abortions)
[11]. Their study was based on a regional BD register.
There are 22 forms of BD (20 isolated forms, Down’s
syndrome and multiple BD) for which registration is
now obligatory in Russia (see Table 1 for list) [5,12,13].
The monitoring of BD in the RF is conducted by the
Moscow Institute of Pediatrics and Children Surgery;
their data contains information for 42 regional registers
in addition to that for the Moscow Oblast mentioned
above [12]. Based on this source, the prevalence in 2011 of
all BD in RF was 23.2/1000 newborns and spanned from
7.0/1000 in Stavropol County to 50.0/1000 in Severnaya
Osetia-Alanya County. By comparison, the prevalence of
the mandatory BD in the RF for 2011 was 7.0/1000Table 1 Birth defects that require mandatory reporting in
the Russian Federation [11]





Anophthalmos, microophthalmos Q11.0, Q11.2
Anotia, microtia, Q16.0, Q17.2
Transposition of large vessels Q20.3
Hypoplastic left heart Q23.4
Cleft palate Q35
Cleft lip with or without cleft palate Q36.0, Q36.9, Q37
Oesophageal atresia Q39.0 – Q39.4
Ano-rectal atresia Q42.0 – Q42.3
Hypospadias Q54.0 – Q54.3, Q54.8, Q54.9
Renal agenesis or disgenesis Q60.1, Q60.4, Q60.6
Epispadias Q64.0
Urine bladder exstrophy Q64.1




Multiple congenital malformations Q89.7
Down syndrome Q90newborns and ranged from 2.8/1000 newborns in Magadan
County to 13.5/1000 in Ivanovo County; in Arkhangelsk
County it was 10.5/1000 for all BD and 7.0/1000 for
mandatory registered BD [13].
A county-wide population-based birth register estab-
lished in 2005 for Murmansk County has facilitated more
detailed investigation of BD epidemiology at the popula-
tion level. Since living in an industrialized region of the
North-west Russian Arctic might influence reproductive
health and pregnancy outcomes, the city of Monchegorsk
located in the Kola Peninsula was selected for an ana-
lysis of the total prevalence of BD, the types observed,
and changes therein during the period 1973–2011.
Monchegorsk is the one of largest cities in Murmansk
County (Figure 1) with 47 403 inhabitants in 2012 [14],
and its nickel refinery complex has been and remains the
largest employer. The official birth rate in Monchegorsk in
2012 was 11.3/1000 and resembled the regional birth rate
(11.8/1000); perinatal mortality rates were also comparable
(respectively, 7.47/1000 and 7.22/1000) [14]. Similarly, for
all of Russia the 2012 rates were 13.3/1000 (of births) and
8.6/1000 (perinatal mortality) [15].
The aim of the study was to estimate the prevalence
and structure of BD during 1973–2011 in Monchegorsk,
Northwest Russia, using established Russian birth regis-
ters and EUROCAT guidelines.Methods
Population and sources of information
The study population included all newborns delivered in
Monchegorsk and registered in either the Kola Birth
Register (KBR) or the Murmansk County Birth Register
(MCBR) for the years 1973–2011.Figure 1 Map of Murmansk County with surrounding areas
(with permission of www.briard.ru).
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collection of information about all births from week 28 of
gestation on that occurred in Monchegorsk as of March
1973. Registration was continued prospectively until 2005.
In addition, 102 newborns with age 13–27 weeks of gesta-
tion were also registered, of which 82 were stillborn or
died during the first week of life. Details of the con-
struction and description of the register’s suitability for
epidemiological investigations have been published [8,9,16].
A total number of 26 841 pregnancy outcomes were regis-
tered. The implementation and use of the KBR demon-
strated the need for a medical birth registry for the entire
Murmansk region (also referred to as the Kola Peninsula).
The MCBR was established in 2005, and the prospect-
ive registration of pregnancy outcomes from 22 weeks of
gestation began on the 1st of January 2006 [17]. A total
of 3750 births in Monchegorsk were registered during
2006–2011.
Data from the two registers were merged into one data-
base using the same fields: maternal date of birth; child’s
birth date; and status of child (LB or SB); BD diagnosis
and its ICD-10 code. Newborns were excluded from the
study if diagnoses at birth had been missed, or its inter-
pretation had been uncertain (i.e., not having an ICD-10
code). We also excluded newborns with missing data
about their status at birth. The total number of excluded
newborns was 144 (0.5%), and thus 30448 newborns were
included in the current analysis.
The registration of BD in the two registers included
information about the existence of BD and its diagnosis;
the latter was based on primary medical documentation
(up to five fields of diagnosis), and were coded according
to ICD-10. The diagnosis was usually made by a pediatrician
or neonatologist after birth and during the maternity house
stay. Use of pertinent diagnostic tools such as ultrasound
examination (US) or echocardiography supplemented
routine examinations. In some cases, prenatal US evi-
dence for suspected BD was confirmed by examination
after birth. In case of abortion or fetal death, the diag-
nosis was based on autopsy results.
Data analysis
The prevalence, structure of BD, and distribution of the
different forms were estimated based on the two- and
three-level of International Classification of Disease, the
Tenth Edition (ICD-10), Chapter XVII, Q codes. The
newborns with more than one BD diagnosis were included
in the analysis only as newborns with multiple defects as
their diagnoses were not coded as Q89.7 (“multiple con-
genital malformations, not elsewhere classified”). These
newborns were not included for any specific defects they
had.
The total prevalence and prevalence by BD groups were
calculated using the number of newborns (LB plus SB)with BD as the numerator, with the total number of
newborns included as the denominator. To make the
prevalence data more comparable with those of EUROCAT,
we calculated the total BD prevalence and that of all BD
malformation groups after excluding all minor anomalies
according to the EUROCAT Guide 1.4, Chapter 3.2:
“Minor malformation for exclusion” from the total num-
ber of BD [18]. The prevalence of malformations for which
registration was mandatory in the RF was calculated using
the sum of newborns with the BD items listed in Table 1
as the numerator.
Descriptive statistics were calculated using SPSS 21.0.
The rates are presented per 1000 newborns (LB plus SB),
with 95% confidence intervals (95% CI). A time-trend cal-
culation was done for four 10-years periods (the last one
included nine years) using chi-squared test for trend.
Ethical considerations
The Committee for Research Ethics at the Northern State
Medical University (Arkhangelsk, Russia) and REK Regional
Committee for Health and Research Ethics, Northern
Norway (Tromsø, Norway) approved the current study.
Results
There were 1099 newborns with BD in Monchegorsk dur-
ing the 1973–2011 study period. The total prevalence was
36.1/1000 newborns (95% CI = 34.0-38.2). There were 96
cases (8.7%) of multiple BD [3.2/1000 (95% CI = 2.5-3.8)]
among them. The prevalence among LB was 34.7/1000
(95% CI = 32.6-36.9), and 167.3/1000 for SB (95% CI =
123.4-211.2). The most prevalent defect groups were
congenital malformations and deformations of the mus-
culoskeletal system, which represented 35.4% of all birth
defects (i.e., 386 cases).
After exclusion of minor anomalies, 808 cases of BD
among 30448 newborn were identified and resulted in a
prevalence rate of 26.5/1000 (95% CI = 24.6-28.3). Those
for all BD groups were calculated for both the total num-
ber of BD and after the exclusion of minor BD cases; they
are presented in Table 2. Comparable data for the 2008–
2012 period derived from the EUROCAT Prevalence
Tables [1] are presented in Table 3.
The prevalence of BD (LB + SB) for which reporting was
mandatory was 7.3/1000 newborns (95% CI = 6.4-8.3). For
LB it was 6.8/1000 (95% CI = 5.8-7.7) and 67.2/1000 (95%
CI = 38.1-97.2) for SB. The prevalence rates stratified by
specific defects (LB + SB) are summarized in Table 4.
A significant positive time-trend for the total BD preva-
lence among newborns was observed, as well as for
malformations of the nervous system, those involving
‘eye, ear, face and neck’, the genital organs, and of the
urinary system. Changes in BD prevalence across the
four time-periods are summarized in Tables 5 and 6
and depicted in Figure 2. After exclusion of urinary system
Table 2 The perinatal prevalence of birth defects grouped according to ICD-10
Group of birth defect (ICD-10 codes) Total prevalence1 Prevalence, excl. minor anomalies2
Prevalence 95% CI Prevalence 95% CI
Congenital malformations of the nervous system (Q00-Q07) 1.8 1.3-2.2 1.8 1.3-2.2
Congenital malformations of eye, ear, face and neck (Q10-Q18) 0.6 0.3-0.8 0.4 0.2-0.7
Congenital malformations of the circulatory system (Q20-Q28) 2.1 1.6-2.7 2.1 1.6-2.6
Congenital malformations of the respiratory system(Q30-Q34) 1.0 0.6-1.4 0.5 0.2-0.7
Cleft lip and cleft palate (Q35-Q37) 1.2 0.8-1.6 1.2 0.8-1.6
Other congenital malformations of the digestive system (Q38-Q45) 1.2 0.8-1.6 0.8 0.5-1.1
Congenital malformations of genital organs (Q50-Q56) 3.7 3.0-4.4 2.1 1.6-2.6
Congenital malformations of the urinary system (Q60-Q64) 4.4 3.7-5.1 4.3 3.6-5.1
Congenital malformations and deformations of the musculoskeletal system(Q65-Q79) 12.7 11.4-13.9 8.7 7.7-9.7
Other congenital malformations, excluding multiple (Q80-Q89, excluding Q 89.7) 3.6 2.9-4.3 0.9 0.6-1.0
Chromosomal abnormalities, not elsewhere classified (Q90-Q99) 0.7 0.4-1.1 0.7 0.4-1.0
Multiple congenital malformation, not classified 3.2 2.5-3.8 3.0 2.4-3.6
1All BD, including minor defects; per 1000 newborns (LB plus SB).
2All minor anomalies were excluded according to EUROCAT guidelines; per 1000 newborns (LB plus SB).
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2011, the overall prevalence was 31.8/1000 (95% CI = 29.9-
33.8) and the observed time trend became non-significant.
In this instance, the prevalence of BD changed from
22.3/1000 (95% CI = 20.2-26.4) in 1973–1982 to 27.8/1000
(95% CI = 23.3-32.2) in 2003–2011 with a peak of 40.1/1000
(95% CI = 36.3-43.9) in 1983–1992.
Discussion
To define the true incidence of BD is problematic be-
cause of the difficulty of defining the population at risk,
and an inability to take into account the occurrence of
unknown fetal deaths and of unknown pregnancies.
Consequently, prevalence is the recommended measure
[19]. In addition, Mason et al. [19] recommended thatTable 3 Comparison of BD prevalences in Monchegorsk for 2
guidelines) with EUROCAT data for Europe [1]
Group of birth defect
Congenital malformations of the nervous system
Congenital malformations of eye, ear, face and neck
Congenital malformations of the circulatory system
Congenital malformations of the respiratory system
Cleft lip and cleft palate
Other congenital malformations of the digestive system
Congenital malformations of genital organs
Congenital malformations of the urinary system
Congenital malformations and deformations of the musculoskeletal system
Other congenital malformations, excluding multiple
Chromosomal abnormalities, not elsewhere classified
1Prevalence per 1000 newborns (LB plus SB), with 95% CI in parentheses.
2Newborns with multiple malformations were not included in the analysis.the number of stillborn not be included in the denomin-
ator, but acknowledged that not doing so “has relatively lit-
tle impact on the final prevalence estimate”. We included
them to make our results more comparable with the
EUROCAT data. The number of fetal deaths was indeed
relatively small (less than 1%), and thus our findings con-
cur with the above statement.
Comparisons of findings with those from other
studies/registers
Although the observed prevalence of all BD for the study
period was higher than reported in other European regis-
ters [1,20], improved agreement with the latest EUROCAT
data was evident after minor anomalies were excluded.
However, that for the last decade was higher than in003–2011 (excluding minor defects as per EUROCAT
Monchegorsk 2003-20111,2 EUROCAT 2008-20122
1.9 (0.7-3.0) 2.5 (2.5-2.6)
0.7 (0–1.5) 0.6 (0.55- 0.65)
1.1 (0.2-2.0) 8.0 (7.9-8.1)
0.4 (0–0.9) 0.7 (0.65-0.75)
1.1 (0.2-2.0) 1.4 (1.3-1.5)
0.9 (0.1-1.7) 1.8 (1.7-1.9)
3.1 (1.7-4.6) 2.2 (2.1-2.2)
19.1 (15.4-22.7) 3.3 (3.3 – 3.4)
4.6 (2.8-6.4) 4.1 (4.0-4.2)
1.3 (0.3-2.3) 1.2 (1.1–1.3)
0.7 (0–1.5) 3.9 (3.8–4.0)
Table 4 Perinatal prevalence of birth defects in
Monchegorsk that require mandatory reporting in the
Russian Federation




Anencephaly 7 0.2 (0.1-0.4)
Spina bifida 17 0.6 (0.3-0.8)
Encephalocele 0 0
Congenital hydrocephalus 31 1.0 (0.7-1.4)
Anophthalmos, microophthalmos 2 0.1 (0–0.2)
Anotia, microtia, 2 0.1 (0–0.2)
Transposition of large vessels 1 0.03 (0–0.1)
Hypoplastic left heart 0 0
Cleft palate 16 0.5 (0.3-0.8)
Cleft lip with or without cleft palate 27 0.9 (0.6-1.2)
Oesophageal atresia 6 0.2 (0–0.4)
Ano-rectal atresia 3 0.1 (0–0.2)
Hypospadias 53 1.7 (1.3-2.2)
Renal agenesis or disgenesis 2 0.1 (0–0.2)
Epispadias 1 0.03 (0–0.1)
Urine bladder exstrophy 3 0.1 (0–0.2)
Reducing limb malformations 13 0.4 (0.2-0.7)
Diaphragmatic hernia 1 0.03 (0–0.1)
Omphalocele 4 0.1 (0–0.3)
Gastroschisis 2 0.1 (0–0.2)
Multiple congenital 2 0.1 (0–0.2)
Down Syndrome 30 1.0 (0.6-1.3)
Total rate of BD mandatory for
registration
223 7.3 (6.4-8.3)
1Prevalence per 1000 newborns (LB plus SB) and 95% CI.
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A comparison of our results with other available Russian
monitoring data shows that in Monchegorsk the total
prevalence was also higher than the mean Russian value
for the 2003–2011 period. By contrast, the prevalences for
BD that require mandatory reporting were approximately
equal [13]. However, use of official monitoring data in theTable 5 Prevalence of BD in Monchegorsk, stratified by time-
Prevalence1 73-82 83-92
Total perinatal prevalence 23.5 40.5
(20.4-26.6) (36.7-44.3
Prevalence by EUROCAT guideline 17.7 26.0
(15.0-20.4) (22.9-29.1
Mandatory BD (22 forms) 4.8 7.6
(3.4-6.3) (5.9-9.3)
1Per 1000 newborns (LB plus SB) with the 95% CI presented in parentheses.assessment of BD prevalences likely involve less rigorous
data collection than that exercised for birth registers, and
perhaps is also prone to under-reporting less severe forms
of defects. Our prevalence estimates of genital malforma-
tions and defects of musculoskeletal system were lower
than those reported for Monchegorsk by Vaktskjold et al.
[8,9]. Our neural tube and anterior abdominal wall de-
fect prevalences were also lower than those reported
for Arkhangelsk by Petrova and Vaktskjold as incidences
(abortions after 12 weeks of gestation were included)
[10,11].
Compared to EUROCAT data (1980–2011) [1,20], the
prevalence of cardiovascular malformations in Monchegorsk
was lower; those of musculoskeletal and urinary BD were
higher; and of comparable magnitude for other malforma-
tions (see Table 3). Prevalences of the severe malformations
for which registration in Russia is mandatory were mostly
similar, but were higher for Down syndrome, severe cardio-
vascular malformations and diaphragmatic hernia. A likely
reason for this is that EUROCAT includes cases of ter-
mination of pregnancy due to fetal anomaly (TOPFA),
while in the RF mandatory autopsies of aborted fetuses
are performed only after 22 weeks of gestation.
The low rate of cardiovascular defects in Monchegorsk
can at least be partly explained by an underestimation of
the true number of minor chamber defects because of an
absence of symptoms during the first week of life. A pre-
natal diagnosis in regional districts of severe malformation
that potentially could be surgically corrected may have
led to a transfer of a delivery to regional (Murmansk)
or federal (Moscow) centers. Such births were not reg-
istered in either of the registers.
Our data for BD that required mandatory reporting are
comparable with those available from the Medical Birth
Registry of Norway [21] for the same time frame. However,
the following prevalences were higher in Norway: transpos-
ition of great vessels (0.21/1000), cleft lip with or without
cleft palate (1.36/1000), Down Syndrome (1.34/1000), and
lower for congenital hydrocephalus (0.43/1000) [21]. The
total prevalence of all defects and deformations in the ob-
servation period years was also comparable, although the
Norwegian data includes TOPFAs from 2000 and based on
this we might expect lower values if they had not been.periods







Table 6 Prevalence1 of groups of BD in Monchegorsk, stratified by time-period
Group of birth defect 73-82 83-92 93-02 03-11 p-value for trend
Congenital malformations of the nervous system 0.8 2.0 2.8 1.9 0.04
(0.2-1.3) (1.2-2.9) (1.4-4.2) (0.7-3.9)
Congenital malformations of eye, ear, face and neck 0.2 0.3 1.1 1.1 0.02
(0–0.5) (0–0.6) (0.2-1.9) (0.2-2.0)
Congenital malformations of the circulatory system 2.4 1.9 2.8 1.3 0.37
(1.4-3.4) (1.1-2.8) (1.4-4.2) (0.3-2.3)
Congenital malformations of the respiratory system 1.3 0.6 1.4 0.6 0.38
(0.6-2.1) (0.1-1.1) (0.4-2.4) (0–1.2)
Cleft lip and cleft palate 1.3 0.7 2.1 1.9 0.46
(0.6-2.1) (0.2-1.2) (0.9-3.3) (0.3-2.3)
Other congenital malformations of the digestive system 1.4 1.3 0.7 1.1 0.37
(0.7-2.2) (0.6-2.0) (0–1.4) (0.2-2.0)
Congenital malformations of genital organs 1.8 4.6 4.9 3.9 0.02
(0.9-2.6) (3.3-5.9) (3.1-6.8) (2.2-5.6)
Congenital malformations of the urinary system 0.2 0.4 4.4 19.1 <0.0001
(0–0.5) (0–0.8) (2.7-6.1) (15.4-22.7)
Congenital malformations and deformations of the musculoskeletal system 8.3 17.3 13.6 10.2 0.39
(6.5-10.2) (14.8-19.8) (10.6-16.6) (7.5-12.9)
Other congenital malformations, excluding multiple 2.4 6.6 1.4 2.2 0.14
(1.4-3.4) (5.0-8.2) (0.4-2.4) (1.0-3.5)
Chromosomal abnormalities, not elsewhere classified 1.0 0.6 0.5 0.7 0.51
(0.3-1.6) (0.1-1.1) (0–1.1) (0–1.5)
Multiple congenital malformation, not classified 2.3 4.2 2.8 3.0 0.71
(1.3-3.3) (2.9-5.4) (1.4-4.2) (1.5-4.4)
1Newborns with all BD were included in the analysis; per 1000 newborns (LB plus SB), with 95% CI in brackets.
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The positive trend of the total BD prevalence across the
study period could be the result of an increase in the
prevalence of congenital malformations of the genital or-
gans and urinary system. However, the interpretation of
such dependence is complex and might well reflect changes
in the health-care system, birth registration protocols, the
socio-economic situation and changes in coding practices
(the KBR was established retrospectively and historical
codes were re-assigned during the past 40 years to conform
with ICD-10). Furthermore, the prevalence of compatible-
with-living defects, such as urinary malformations, has in-
creased because most of them can be easily visualized by
US-screening [22]. Interestingly, the most severe BD that
are often incompatible with life (such as anencephaly) did
not exhibit substantial changes in prevalence after the
1970–1980 period. This observation presumably reflects
an impact of prenatal diagnostics established in 1994,
which included one US examination and more com-
plex prenatal screening procedures after the year 2000.
Evidently, these improvements in the prenatal detectionled to the reduction of severe malformations and better
diagnosis of minor ones at the first week of life.
An increase in the prevalence of urinary system mal-
formations during 2003-2011was no doubt influenced
by an increase of two defects, namely Q62.0 (congenital
hydronephrosis) and Q63.0 (another malformations of
kidney, unspecified). Both forms could be symptomless
during the first days of life and thus could only have been
diagnosed during the time-frame when US-examinations
were conducted. On the other hand, the observed in-
creased occurrence of these forms could also reflect over
diagnosis, but this would require a detailed follow-up
study to verify.
Increased prevalence of BD over time could also repre-
sent a true rise, perhaps due to environmental factors. For
example, the prevalence of some group of BD (malforma-
tions of genital organs, musculoskeletal abnormalities and
multiple BD) rose two- to three-fold between 1973 and
1992, which overlaps increased production at the local
nickel refinery complex that reached a maximum between
1982 and 1988. The observed peak in BD prevalence
Figure 2 Prevalence of all birth defects and the most prevalent groups of defects in Monchegorsk, stratified by calendar periods.
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defects) also coincides. The primary pollutants were sulfur
dioxide and particulates containing a suite of inorganic el-
ements including toxic metals and nonmetals [23]. The
latter can accumulate in soil and be transferred to the
watershed over time. Although these emissions have been
systematically reduced since the early 1990s, they remain
substantial. Other possible explanations of increasing
BD prevalence include higher maternal age and an in-
crease in alcohol abuse and smoking among mothers;
specifically, 30.8% of women in Russia of reproductive
age were smokers in 2008–2010 [24] compared to 19% in
1990 [25].
Study strengthens and limitations
Our study is the first to examine all types BD prevalences
recorded in two population-based registers in Russia that
can be compared with European registers. A possible
limitation of our study pertains to the retrospectively
established KBR database. Only diagnoses made in the
maternity houses were taken into account, which could
be a reason for underestimation. Minor anomalies or
defects that might be revealed later (e.g., small septal
heart defects without heart failure) were not identified.
Neither were TOPFAs included in either database, which
could mean that the prevalence could be higher than cal-
culated after the year 2000 when prenatal screening was
established. On the other hand and in terms of the register
data, only a small number of newborns had missing infor-
mation (0.5%). Difference in the gestational age limits of
registration of the newborns in the merged registries andretrospective type of data collection in the KBR could po-
tentially have influenced the results, although this would
not explain the total BD prevalence increase seen for
2003–2011. There were 17 newborns under 28 weeks in
2006–2011 registered in the MCBR. Among them, only
three additional cases of BD were found and the total
number of newborns with BD for that period was 134.
Inclusion of these data did not change the BD prevalence
significantly. Furthermore, when the 102 newborns with
gestational age less than 28 weeks noted in the KBR were
included in the analysis, there was also little impact on
our findings. One might have expected the prevalence of
the most severe BD to have increased as well, but we did
not observe this.
Conclusion
The perinatal prevalence of BD in Monchegorsk increased
during the study period and was 36.1 per 1000 newborns
overall. The most prevalent groups of defects were muscu-
loskeletal and urinary malformations. Investigation of the
possible reasons for these findings is recommended.
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